Can-Fite BioPharma (CANF) Receives Notice of Allowance in Europe for Piclidenoson-Related Patent
Tweet Send to a Friend
Can-Fite BioPharma Ltd. (NYSE: CANF) announced that it has received a Notice of Allowance from the European Patent Office indicating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
